103 related articles for article (PubMed ID: 21471644)
41. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
[TBL] [Abstract][Full Text] [Related]
42. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type.
Javed H; Khan MM; Khan A; Vaibhav K; Ahmad A; Khuwaja G; Ahmed ME; Raza SS; Ashafaq M; Tabassum R; Siddiqui MS; El-Agnaf OM; Safhi MM; Islam F
Brain Res; 2011 May; 1389():133-42. PubMed ID: 21376020
[TBL] [Abstract][Full Text] [Related]
43. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
45. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
[TBL] [Abstract][Full Text] [Related]
46. Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
Ishibashi K; Onishi A; Fujiwara Y; Ishiwata K; Ishii K
J Nucl Med; 2015 Feb; 56(2):229-33. PubMed ID: 25572094
[TBL] [Abstract][Full Text] [Related]
47. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus.
Zhou Y; Qu ZQ; Zeng YS; Lin YK; Li Y; Chung P; Wong R; Hägg U
Exp Toxicol Pathol; 2012 Nov; 64(7-8):673-80. PubMed ID: 21242065
[TBL] [Abstract][Full Text] [Related]
48. Long-term follow-up of intracerebroventricular injection of streptozotocin-inducing pain sensitization.
Rostami F; Abbasi Z; Fereidoni M
Behav Pharmacol; 2022 Dec; 33(8):542-550. PubMed ID: 36256700
[TBL] [Abstract][Full Text] [Related]
49. XperCT-guided Intra-cisterna Magna Injection of Streptozotocin for Establishing an Alzheimer's Disease Model Using the Cynomolgus Monkey (
Park J; Won J; Jeon CY; Lim KS; Choi WS; Park SH; Seo J; Cho J; Seong JB; Yeo HG; Kim K; Kim YG; Kim M; Yi KS; Lee Y
Exp Neurobiol; 2022 Dec; 31(6):409-418. PubMed ID: 36631849
[TBL] [Abstract][Full Text] [Related]
50. Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
Ma Y; Johnston TH; Peng S; Zuo C; Koprich JB; Fox SH; Guan Y; Eidelberg D; Brotchie JM
Mov Disord; 2015 Aug; 30(9):1283-8. PubMed ID: 26377152
[TBL] [Abstract][Full Text] [Related]
51. Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.
Ebel DL; Torkilsen CG; Ostrowski TD
J Alzheimers Dis; 2017; 56(3):1197-1211. PubMed ID: 28106557
[TBL] [Abstract][Full Text] [Related]
52. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats.
Duelli R; Schröck H; Kuschinsky W; Hoyer S
Int J Dev Neurosci; 1994 Dec; 12(8):737-43. PubMed ID: 7747600
[TBL] [Abstract][Full Text] [Related]
53. The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis).
Koulmanda M; Qipo A; Chebrolu S; O'Neil J; Auchincloss H; Smith RN
Am J Transplant; 2003 Mar; 3(3):267-72. PubMed ID: 12614280
[TBL] [Abstract][Full Text] [Related]
54. 18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress.
Miceli A; Cossu V; Marini C; Castellani P; Raffa S; Donegani MI; Bruno S; Ravera S; Emionite L; Orengo AM; Grillo F; Nobili F; Morbelli S; Uccelli A; Sambuceti G; Bauckneht M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142766
[TBL] [Abstract][Full Text] [Related]
55. Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin.
Grieb P; Kryczka T; Fiedorowicz M; Frontczak-Baniewicz M; Walski M
Acta Neurobiol Exp (Wars); 2004; 64(4):481-9. PubMed ID: 15586665
[TBL] [Abstract][Full Text] [Related]
56. Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer's Disease.
Lin LF; Jhao YT; Chiu CH; Sun LH; Chou TK; Shiue CY; Cheng CY; Ma KH
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215222
[TBL] [Abstract][Full Text] [Related]
57. Intracerebroventricular administration of streptozotocin as an experimental approach to Alzheimer's disease.
Kalafatakis K; Zarros A
Int J Neurosci; 2014 Dec; 124(12):944-6. PubMed ID: 24494726
[TBL] [Abstract][Full Text] [Related]
58. Synaptic loss and amyloid beta alterations in the rodent hippocampus induced by streptozotocin injection into the cisterna magna.
Ahn Y; Seo J; Park J; Won J; Yeo HG; Kim K; Jeon CY; Huh JW; Lee SR; Lee DS; Lee Y
Lab Anim Res; 2020; 36():17. PubMed ID: 32551298
[TBL] [Abstract][Full Text] [Related]
59. Ketone bodies as a therapeutic for Alzheimer's disease.
Henderson ST
Neurotherapeutics; 2008 Jul; 5(3):470-80. PubMed ID: 18625458
[TBL] [Abstract][Full Text] [Related]
60. Sex Differences in the Effect of Diabetes on Cerebral Glucose Metabolism.
Wu CY; Lin YH; Hsieh HH; Lin JJ; Peng SL
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
